1. Home
  2. BBIO vs HLI Comparison

BBIO vs HLI Comparison

Compare BBIO & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$65.93

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

HOLD

Current Price

$149.43

Market Cap

10.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBIO
HLI
Founded
2015
1972
Country
United States
United States
Employees
N/A
2702
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
12.7B
10.4B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
BBIO
HLI
Price
$65.93
$149.43
Analyst Decision
Strong Buy
Buy
Analyst Count
25
7
Target Price
$86.33
$194.29
AVG Volume (30 Days)
2.8M
616.4K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
1.54%
EPS Growth
N/A
41.61
EPS
N/A
4.74
Revenue
$502,076,000.00
$2,389,416,000.00
Revenue This Year
$89.45
$13.77
Revenue Next Year
$73.78
$12.10
P/E Ratio
N/A
$32.10
Revenue Growth
126.26
24.81
52 Week Low
$31.77
$134.41
52 Week High
$84.94
$211.78

Technical Indicators

Market Signals
Indicator
BBIO
HLI
Relative Strength Index (RSI) 40.81 43.92
Support Level $61.95 $146.58
Resistance Level $68.71 $184.59
Average True Range (ATR) 2.84 4.39
MACD -0.25 -0.48
Stochastic Oscillator 28.22 25.00

Price Performance

Historical Comparison
BBIO
HLI

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

Share on Social Networks: